Mitochondrial complex I inhibitor

This page covers all Mitochondrial complex I inhibitor drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Mitochondrial complex I (NADH dehydrogenase).

Targets

Mitochondrial complex I (NADH dehydrogenase)

Phase 3 pipeline (2)

• Debio 4126 · Debiopharm International SA · Oncology
  Debio 4126 is a selective inhibitor of mitochondrial complex I that disrupts energy metabolism in cancer cells.
• Debio 4326 · Debiopharm International SA · Oncology
  Debio 4326 is a selective inhibitor of mitochondrial complex I that disrupts energy metabolism in cancer cells.